Posted in | News | Gold

Lupaka Gold Announces Additional Assay Results from Crucero Gold Project

Lupaka Gold has reported the assay results of six further drill holes from the current drilling conducted at its Crucero Gold project, south Peru. It has encountered wide mineralized intercepts at the project.

Plan View of A-1 Zone at Crucero Project

The company has intersected 3.11 g/t gold over 10.1 m, 2.10 g/t gold over 37.0 m, 1.94 g/t gold over 14.0 m and 1.64 g/t gold over 19.0 m in the hole DDH-37, 7.33 g/t gold over 6.0 m, 3.20 g/t gold over 8.4 m, 1.82 g/t gold over 37.0 m in the hole DDH-38, 5.98 g/t gold over 5.0 m and 1.47 g/t gold over 27.0 m in the hole DDH-44 and 1.20 g/t gold over 48.0 in the hole DDH-46.

Lupaka Gold has drilled 17 holes and more than 5,400 m from the beginning of the 2011 drilling campaign. Assays from the primary exploratory hole drilled at the A-11 zone are pending. The target of the 2011 drilling is on the resource extension at the A-1 zone and this drilling examines further anomalies discovered at the 5,500 ha claim region.

The CEO and President of Lupaka Gold, Eric Edwards has stated that the latest drill program has demonstrated the strength, consistency and growth prospective of the mineralization over the A-1 zone. Main mineralized intercepts were encountered in the hole DDH-38 located at the Crucero project.

Additionally, the company has drilled DDH-47 and DDH-48 holes but did not encounter significant assays. It drilled these holes outside the existing mineralization envelope for analyzing the mineralization’s potential eastward expansion.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). Lupaka Gold Announces Additional Assay Results from Crucero Gold Project. AZoMining. Retrieved on November 22, 2024 from https://www.azomining.com/News.aspx?newsID=5356.

  • MLA

    Scanlon, Joel. "Lupaka Gold Announces Additional Assay Results from Crucero Gold Project". AZoMining. 22 November 2024. <https://www.azomining.com/News.aspx?newsID=5356>.

  • Chicago

    Scanlon, Joel. "Lupaka Gold Announces Additional Assay Results from Crucero Gold Project". AZoMining. https://www.azomining.com/News.aspx?newsID=5356. (accessed November 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. Lupaka Gold Announces Additional Assay Results from Crucero Gold Project. AZoMining, viewed 22 November 2024, https://www.azomining.com/News.aspx?newsID=5356.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.